BIVENTRICULAR PACING AND INTRACARDIAC DEFIBRILLATOR
Biventricular Pacing For Heart
Failure
Patients with left ventricular failure often have asynchrony of the left ventricle that results in delayed lateral-wall electrical activation and mechanical contraction of the lateral LV wall, disorganized LV contraction, decreased efficiency of the LV pumping chamber, and often mitral regurgitation. ECG reveals a conduction block manifested as left bundle branch block (LBBB). When this asynchrony is related to impaired conduction, the septum may contract normally but the LV free wall may not. In general, the wider the QRS complex in LBBB, the better are the results of biventricular (BiV) pacing. The purpose of biventricular pacing is to synchronize contraction of the septum and the LV free wall (see Plate 6-138).
Thus the BiV pacing device, when working properly, is
responsible for chronic resynchronization therapy. CRT organizes the
ventricular activation sequence by coordinating septal free wall contraction,
which improves pumping
efficiency of the left ventricle, diminishes mitral regurgitation and increases
cardiac output, and facilitates management of severe cardiac failure patients.
In order for this device to work properly, the septum and the lateral LV wall
must be viable. Thus, failure to improve
ventricular function can occur in patients with lateral-wall or septal MIs.
The generator for endocardial pacing
systems is inserted into a pocket commonly made below the mid- clavicle. The
endocardial lead system of an atrioventricular (A-V) dual-chamber pacemaker is
usually introduced through the subclavian vein, which becomes the basic pacing
unit. An additional lead system is added to pace the LV free wall. The new
catheter lead is introduced into the coronary sinus, then advanced to a marginal vein so that it paces the epicardial
surface of the LV free wall. Thus the septum is paced by the intraventricular
route from the right ventricle and the LV lateral wall is paced epicardially.
Intracardiac Defibrillator In Heart Failure Patients
Patients in heart failure who are to
receive a biventricular pacing device also often receive a BiV intracardiac defibrillator, or implantable
cardioverter-defibrillator (ICD), because most have poor LV function (EF
<35%) and are at high risk for sudden cardiac death. The ICD has become the
dominant therapy for the treatment of these patients. Randomized trials have
shown that ICDs reduce mortality from sudden cardiac death in those patients
resuscitated from a cardiac arrest caused by ventricular tachycardia (VT).
Antiarrhythmic drugs (e.g., amiodarone, sotalol) are used as adjunctive therapy
to reduce frequent ICD shocks in these patients.
The ICD is similar to a typical
pacemaker, but the generator is slightly larger than the usual pacemaker
generator. In all aspects, the implantation procedure is similar to that of
standard pacemaker implantation. The venous access and pocket for the device
are the same as for a dual-chamber pacemaker: the subcutaneous region below the
midclavicle. Because of the numerous functions of an implantable cardiac defibrillator
(e.g., cardioverter, defibrillator, and pacemaker), the device is slightly
larger than a standard pacemaker. All ICD leads have tip electrodes than can
sense the heart rate and deliver an electrical stimulus to pace the heart (see Plate 6-139).
Various models of defibrillators are
available. In general, when a serious arrhythmia (e.g., VT) is detected, the
ICD can be programmed to “burst pace” at a rate higher than the VT. The burst
pacing is then abruptly terminated, and often the VT is converted to sinus
rhythm. If the device fails to convert the arrhythmia, the energy required for
defibrillation will ramp up, and the patient will be shocked. All ICDs have
built-in ability to interpret the device for rhythm
disturbances, to determine which arrhythmia was cardioverted or shocked. Most
often the device is programmed to detect a heart rate, above which the device
will activate with burst pacing or shocks. Until recently, pacemakers and ICDs
were not magnetic resonance compatible, but most manufacturers now are working
to make MR-compatible ICDs.

